Code |
Product Name |
CAS No |
End Use/API Name |
Thereupatic use |
No result |
IN-HOUSE - REGULAR |
TPT-001 |
4-Aminosalicyclic acid (PASA) |
65-49-6 |
Mosapride | Amisulpride |
Anti-psychotic |
TPT-002 |
Methyl 4-Amino-5-ethylsulfonyl-2-methoxybenzoate |
80036-89-1 |
Amisulpride |
Anti-psychotic |
TPT-003 |
4-Amino-5-ethylsulfonyl-2-methoxybenzoic acid (AMI ACID) |
71675-87-1 |
Amisulpride |
Anti-psychotic |
TPT-004 |
Meta-Chloroanisole (MCA) |
2845-89-8 |
Tramadol | Tapentadol |
Analgesic |
TPT-005 |
N,N'-Carbonyldiimidazole (CDI) |
530-62-1 |
KSM |
- |
TPT-006 |
N-(Triphenylmethyl)-5-(4'bromomethyl-biphenyl-2-yl)tetrazole (TTBB) |
124750-51-2 |
Losartan | Olmesartan |
Anti-hypertensive |
TPT-007 |
2,4-Dichloropyrimidine (2,4-DCP) |
3934-20-1 |
Osimertinib | Pazopanib |
Anti-cancer |
TPT-008 |
6-Chloro-2,4-Diaminopyrimidine |
156-83-2 |
Minoxidil |
Anti-hypertensive |
TPT-009 |
2-Amino-3-hydroxypyridine |
16867-03-1 |
KSM |
- |
TPT-010 |
2,4-Dichloro-5-trifluoromethylpyrimidine |
3932-97-6 |
Rociletinib | Defactinib |
Anti-lung cancer |
TPT-011 |
3H-Oxazolo[4,5-b]pyridin-2(3H)-one |
60832-72-6 |
KSM |
- |
TPT-012 |
2-Chloropyrimidine |
1722-12-9 |
Piribedil | Filorexant |
Anti-parkinson |
TPT-013 |
2-Chloro-6-methylaniline |
87-63-8 |
Dasatinib|Butanilicaine |
Anti-kinetic |
TPT-014 |
2,4-Dichloro-5-fluoropyrimidine |
2927-71-1 |
Voriconazole | Spebrutinib |
Anti-Fungal |
TPT-015 |
Methyl-6-methylpicolinate |
13602-11-4 |
Galunisertib |
Anti-cancer |
TPT-016 |
4-Bromo-3-Chlorobenzonitrile |
57418-97-0 |
KSM |
- |
TPT-017 |
2-Bromopyrimidine |
4595-60-2 |
KSM |
- |
TPT-018 |
5-Bromo -2-Chloropyrimidine |
32779-36-5 |
Macitentan |
Anti-hypertensive |
TPT-019 |
5-bromo-2-chloro-4’-ethoxydiphenylmethane |
461432-23-5 |
Dapagliflozin |
Anti-diabetic |
TPT-020 |
5-Bromo-2-chlorobenzoic acid |
21739-92-4 |
Dapagliflozin | Empagliflozin |
Anti-diabetic |
IN-HOUSE - CAMPAIGN |
TPT-021 |
2,4,5-Trimethoxybenzoic Acid |
490-64-2 |
Acotiamide |
Anti-gastrointestinal |
TPT-022 |
Ethyl 2-amino-1,3-thiazole-4-carboxylate |
5398-36-7 |
Acotiamide |
Anti-gastrointestinal |
TPT-023 |
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
262368-30-9 |
Nintedanib |
Anti-cancer |
TPT-024 |
Ethyl 2-Amino-4-methylthiazole-5-carboxylate |
7210-76-6 |
Febuxostat |
Anti-gout |
TPT-025 |
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate |
160844-75-7 |
Febuxostat |
Anti-gout |
TPT-026 |
1-(3-ethyl-4-(hydroxymethyl)phenyl)Phenyl)Ethanone |
1378888-43-7 |
Siponimod |
Anti-sclerosis |
TPT-027 |
4-Bromomethyl-cyclohexy2-trifluoro-methybenzene |
800381-60-6 |
Siponimod |
Anti-sclerosis |
TPT-028 |
3-Azetidinecarboxylic acid |
36476-78-5 |
Siponimod |
Anti-sclerosis |
TPT-029 |
Azetidine-3-carboxylic acid methyl ester |
343238-58-4 |
Siponimod |
Anti-sclerosis |
TPT-030 |
(3R)-3-(4-bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
1146629-83-5 |
Ruxolitinib |
Anti-cancer |
TPT-031 |
4-chloro-7h-pyrrolo[2,3-d]pyrimidine |
3680-69-1 |
Ruxolitinib | Tofacitinib |
Anti-cancer |
TPT-032 |
2,6-difluorophenyl)methanamine |
69385-30-4 |
2,6-Difluorobenzyl alcohol |
- |
TPT-033 |
6-Chloropyrazine-2-carboxylic acid |
23688-89-3 |
KSM |
- |
TPT-034 |
2-Amino-4-methylpyrimidine |
108-52-1 |
Azanidazole |
Anti-bacterial |
TPT-035 |
4-Nitrophenethylamine hydrochloride |
29968-78-3 |
Mirabegron |
Anti-muscarinic |
TPT-036 |
(1R)-2-[[2-(4-Aminophenyl)ethyl]amino]-1-phenylethanol |
391901-45-4 |
Mirabegron |
Anti-muscarinic |
TPT-037 |
(S)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride |
1213099-69-4 |
Ozanimod |
Anti-inflammatory |
TPT-038 |
2,3-dihydro-1-oxo-1H-indene-4-carbonitrile |
60899-34-5 |
Ozanimod |
Anti-inflammatory |
TPT-039 |
(R)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate |
1306763-31-4 |
Ozanimod |
Anti-inflammatory |
TPT-040 |
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride |
25952-53-8 |
Ozanimod |
Anti-inflammatory |